Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Cancer Treatment Access in South Africa Lags Behind New Therapies

Learn why cancer treatment access in South Africa lags new therapies, from outdated PMBs and scheme co-payments to provincial budgets and the missing HTA.
Cancer Treatment Access in South Africa Lags Behind New Therapies
Image | Khanchit Khirisutchalual | iStock/2213157127

Cancer treatment access in South Africa is falling behind global advances, as affordability shuts many out of newer therapies. Public-sector patients are largely excluded, while medical scheme members may face funding refusals or high co-payments.

Cancer is covered under prescribed minimum benefits (PMBs), which schemes must fund regardless of plan. However, the regulations define which diagnoses and treatments qualify.

Continue reading with a Health Matters subscription

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in

Not ready to subscribe? Get Health Matters Weekly free: the week’s top healthcare headlines every Friday.

More from Health Matters

19.11.2026

Learn how Durban port delays are holding up 30 medicine shipments as the health department's shortage hotlist doubles and SAHPRA enforcement bites.

19.11.2026

Learn how Gauteng unpaid invoices of R3.6bn are fuelling medicine shortages, as suppliers withhold stock and patients buy medicines privately.

18.11.2026

Learn how two former managers allegedly received R61m in the Tembisa Hospital corruption case, as the NPA widens its prosecution of the R635m scandal.